US$ 29.55
does blue cross blue shield cover glp-1 drugs Why we are changing coverage of for weight loss BCBSM pulling back on GLP-1
Description
While we continue to see Novo Nordisk as a wide-moat firm, with strong intangible assets surrounding its cardiometabolic business, we think the high obesity drug demand and scarcity of supply have driven share prices above their intrinsic value

Reagan-Shaw, S., Nihal, M

The presence of a large number of pharmaceutical companies and a high awareness among medical professionals and patients about the benefits of GLP-1 ensure the long-term dominance of the region in the market

413 GLP-1RAs play a neuroprotective role in neurons by facilitating neuronal survival and promoting neuronal growth, thereby preserving the structural and functional integrity of synapses

Fr du forpligter dig, kan du teste svartider via chat eller mail og se, om hjlpen er bde hurtig og prcis

10.2337/diabetes.48.1.86 [DOI] [PubMed] [Google Scholar] Fan J., Shen W., Lee S
